GRISEOFULVIN,ULTRAMICROSIZE (ultramicrosize griseofulvin) by Molecular Devices is clinical pharmacology microbiology - griseofulvin is fungistatic with in vitro activity against various species of microsporum, epidermophyton and trichophyton. Approved for the following ringworm infections. First approved in 2012.
Drug data last refreshed 1w ago
CLINICAL PHARMACOLOGY Microbiology - Griseofulvin is fungistatic with in vitro activity against various species of Microsporum, Epidermophyton and Trichophyton. It has no effect on bacteria or other genera of fungi. Susceptibilitv Testing For specific information regarding susceptibility test…
Tubulin Inhibiting Agent
Worked on GRISEOFULVIN,ULTRAMICROSIZE at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.